PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Topical application of Ulmo honey combined with oral ascorbic acid (500 mg daily) resulted in 100% full healing of venous ulcers in a study of 18 patients [PMID:26039296].
Ulmo honey demonstrates antibacterial and wound-healing capacity in guinea pig burn models [PMID:37252390]. A medical-grade version (Ulmoplus) and its nano-functionalized form with copper nanoparticles also show antibacterial potency and increase fibroblast collagen content [PMID:37765158].
Ulmo honey showed greater antibacterial activity against all tested methicillin-resistant Staphylococcus aureus (MRSA) isolates compared to Manuka honey, and similar activity against E. coli and P. aeruginosa [PMID:20813024].
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 37252390 (2023) — Antibacterial and wound-healing action of Ulmo honey (Eucryphia cordifolia) of differing degrees of purity. · Frontiers in veterinary science
- 2.PMID: 28290363 (2017) — Volatile and non-volatile/semi-volatile compounds and in vitro bioactive properties of Chilean Ulmo (Eucryphia cordifolia Cav.) honey. · Food research international (Ottawa, Ont.)
- 3.PMID: 37760088 (2023) — Antimicrobial, Antioxidant, and Anti-Inflammatory Properties of Monofloral Honeys from Chile. · Antioxidants (Basel, Switzerland)
- 4.PMID: 26039296 (2015) — Combined therapy of Ulmo honey (Eucryphia cordifolia) and ascorbic acid to treat venous ulcers. · Revista latino-americana de enfermagem
- 5.PMID: 40227239 (2025)